Search

everythinglearnresearchcommunity

for

Search:↓

Microfluidics can create precise, efficient delivery systems for food and cosmetics, but scaling up is challenging.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Droplet microfluidics improves efficiency and control in chemistry, biology, and nanotechnology.

Droplet microfluidics can precisely create microgels for advanced bioengineering uses.

A new method quickly creates controllable cell clusters for tissue engineering and drug testing.

Microtechnology methods improve organoid production for medical research.

The study created a new type of microsphere that effectively regrows hair.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

Sodium alginate-based hydrogels are promising for medical use due to their versatility and biocompatibility.

Plant and algal lipid droplets are promising for natural oil production but need better extraction methods.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Bioengineered hair germs using special hydrogels can help regenerate hair follicles and treat hair loss.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Stem cell therapies are advancing quickly with new technologies and need supportive regulations for clinical use.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Hydrogel-based hair follicle organoids could help treat hair loss and improve drug testing.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

3D bioprinting advancements are improving skin regeneration for wound healing and personalized reconstruction.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

New skin repair methods show promise but need to be safer and more accessible.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Plant-based sensors can help in healthcare but need skilled technicians.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The new omeprazole nanoemulgel shows promise as a topical treatment for infections.

Nanoemulgel improves delivery and effectiveness of plant-based drugs for various conditions.